PL353154A1 - Trwała kompozycja farmaceutyczna do stosowania doustnego - Google Patents

Trwała kompozycja farmaceutyczna do stosowania doustnego

Info

Publication number
PL353154A1
PL353154A1 PL00353154A PL35315400A PL353154A1 PL 353154 A1 PL353154 A1 PL 353154A1 PL 00353154 A PL00353154 A PL 00353154A PL 35315400 A PL35315400 A PL 35315400A PL 353154 A1 PL353154 A1 PL 353154A1
Authority
PL
Poland
Prior art keywords
drug
present
oral use
exposure
during storage
Prior art date
Application number
PL00353154A
Other languages
English (en)
Other versions
PL200645B1 (pl
Inventor
Kazuhiro Sako
Toyohiro Sawada
Keiichi Yoshihara
Tatsunobu Yoshioka
Shunsuke Watanabe
Original Assignee
Yamanouchi Pharmaceutical Co, Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22520720&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL353154(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Yamanouchi Pharmaceutical Co, Ltd. filed Critical Yamanouchi Pharmaceutical Co, Ltd.
Publication of PL353154A1 publication Critical patent/PL353154A1/pl
Publication of PL200645B1 publication Critical patent/PL200645B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL353154A 1999-08-04 2000-08-01 Trwała kompozycja farmaceutyczna do stosowania doustnego, trwała tabletka farmaceutyczna do stosowania doustnego, sposób wytwarzania trwałej kompozycji farmaceutycznej oraz zastosowanie żółtego tlenku żelazowego lub czerwonego tlenku żelazowego do stabilizowania preparatu PL200645B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14722299P 1999-08-04 1999-08-04

Publications (2)

Publication Number Publication Date
PL353154A1 true PL353154A1 (pl) 2003-10-20
PL200645B1 PL200645B1 (pl) 2009-01-30

Family

ID=22520720

Family Applications (1)

Application Number Title Priority Date Filing Date
PL353154A PL200645B1 (pl) 1999-08-04 2000-08-01 Trwała kompozycja farmaceutyczna do stosowania doustnego, trwała tabletka farmaceutyczna do stosowania doustnego, sposób wytwarzania trwałej kompozycji farmaceutycznej oraz zastosowanie żółtego tlenku żelazowego lub czerwonego tlenku żelazowego do stabilizowania preparatu

Country Status (17)

Country Link
EP (1) EP1205190B1 (pl)
JP (1) JP3462490B2 (pl)
KR (1) KR100507400B1 (pl)
CN (1) CN1193792C (pl)
AT (1) ATE324909T1 (pl)
AU (1) AU769807B2 (pl)
CA (1) CA2387705C (pl)
DE (1) DE60027728T2 (pl)
DK (1) DK1205190T3 (pl)
ES (1) ES2262528T3 (pl)
HU (1) HU229295B1 (pl)
MX (1) MXPA02001267A (pl)
NO (1) NO331834B1 (pl)
PL (1) PL200645B1 (pl)
PT (1) PT1205190E (pl)
RU (1) RU2220715C2 (pl)
WO (1) WO2001010466A1 (pl)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04011529A (es) * 2002-04-24 2005-08-15 Cypress Bioscience Inc Prevencion y tratamiento de trastornos somaticos funcionales, incluyendo trastornos relacionados con la tension.
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
ZA200409537B (en) * 2003-01-31 2006-10-25 Yamanouchi Pharma Co Ltd Stable solid medicinal composition for oral administration
US7442387B2 (en) * 2003-03-06 2008-10-28 Astellas Pharma Inc. Pharmaceutical composition for controlled release of active substances and manufacturing method thereof
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
JP2005162737A (ja) * 2003-11-10 2005-06-23 Astellas Pharma Inc 徐放性医薬組成物
JP2005162736A (ja) * 2003-11-10 2005-06-23 Astellas Pharma Inc 徐放性医薬組成物
US7358270B2 (en) 2004-01-30 2008-04-15 Astellas Pharma Inc. Treating agent for irritable bowel syndrome
RU2253453C1 (ru) * 2004-03-15 2005-06-10 Общество с ограниченной ответственностью "ЮНАЛ" Противовоспалительная и антиаллергическая композиция
DE102004032049A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
RU2279467C1 (ru) * 2005-01-25 2006-07-10 Общество с ограниченной ответственностью "Нурлатский ликеро-водочный завод" Водка "ледок"
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
JP4632204B2 (ja) * 2005-09-21 2011-02-16 アステラス製薬株式会社 下痢型過敏性腸症候群治療剤
TWI478712B (zh) 2008-09-30 2015-04-01 Astellas Pharma Inc 釋控性醫藥組成物
EP2389167A2 (en) * 2009-01-20 2011-11-30 Micro Labs Limited Modified release solid pharmaceutical compositions of trimetazidine and process thereof
BR112012001466A2 (pt) 2009-07-22 2020-08-11 Grünenthal GmbH forma de dosagem resistente à falsificação para opioides sensíveis à oxidação, seu processo de fabricação, e embalagem
ES2534908T3 (es) 2009-07-22 2015-04-30 Grünenthal GmbH Forma de dosificación de liberación controlada extruida por fusión en caliente
RU2442586C1 (ru) * 2009-11-11 2012-02-20 Учреждение Белорусского государственного университета "Научно-исследовательский институт физико-химических проблем" (НИИ ФХП БГУ) Гидрогелевый противоопухолевый препарат
ES2665467T3 (es) 2010-03-29 2018-04-25 Astellas Pharma Inc. Composición farmacéutica de liberación modificada
CA2808219C (en) 2010-09-02 2019-05-14 Gruenenthal Gmbh Tamper resistant dosage form comprising inorganic salt
KR102027912B1 (ko) 2011-02-15 2019-10-02 지엘팜텍주식회사 경구투여용 탐술로신 또는 이의 약제학적으로 허용되는 염을 포함하는 서방성 삼중정제
BR112014002022A2 (pt) 2011-07-29 2017-02-21 Gruenenthal Gmbh comprimido resistente à violação proporcionando liberação de fármaco imediata
JP6063462B2 (ja) 2011-07-29 2017-01-18 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 即時薬剤放出を提供するタンパーレジスタント錠剤
LT2838512T (lt) 2012-04-18 2018-11-12 GrĆ¼nenthal GmbH Pažeidimui atspari ir dozės atpalaidavimo nuokrypiui atspari farmacinė vaisto forma
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
AU2014273227B2 (en) 2013-05-29 2019-08-15 Grunenthal Gmbh Tamper-resistant dosage form containing one or more particles
AU2014289187B2 (en) 2013-07-12 2019-07-11 Grunenthal Gmbh Tamper-resistant dosage form containing ethylene-vinyl acetate polymer
HK1224189A1 (zh) 2013-11-26 2017-08-18 Grünenthal GmbH 通过低温研磨制备粉状药物组合物
WO2015173195A1 (en) 2014-05-12 2015-11-19 Grünenthal GmbH Tamper resistant immediate release capsule formulation comprising tapentadol
US9872835B2 (en) 2014-05-26 2018-01-23 Grünenthal GmbH Multiparticles safeguarded against ethanolic dose-dumping
US10561628B2 (en) 2015-03-19 2020-02-18 Daiichi Sankyo Company, Limited Solid preparation including antioxidant
BR112017019920B1 (pt) * 2015-03-19 2023-11-07 Daiichi Sankyo Company, Limited Preparação sólida farmacêutica, e, método para estabilização de uma preparação sólida farmacêutica
WO2016170097A1 (en) 2015-04-24 2016-10-27 Grünenthal GmbH Tamper-resistant dosage form with immediate release and resistance against solvent extraction
TWI722988B (zh) 2015-06-05 2021-04-01 瑩碩生技醫藥股份有限公司 緩釋性醫藥組合物及其製備方法
CA2998259A1 (en) 2015-09-10 2017-03-16 Grunenthal Gmbh Protecting oral overdose with abuse deterrent immediate release formulations
EP3360866B1 (en) 2017-02-14 2019-01-02 Alfred E. Tiefenbacher (GmbH & Co. KG) Mirabegron prodrugs
JP7312751B2 (ja) 2018-07-30 2023-07-21 第一三共株式会社 安定化剤を含有する医薬品の固形製剤
EP3722285B1 (en) 2020-04-08 2022-03-30 Alfred E. Tiefenbacher (GmbH & Co. KG) Process for preparing mirabegron enacarbil
US12097189B1 (en) 2024-02-09 2024-09-24 Astellas Pharma Inc. Pharmaceutical composition for modified release

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL194389C (nl) * 1984-06-14 2002-03-04 Novartis Ag Werkwijze voor het bereiden van een vaste dispersie van een farmaceutisch actief middel dat een lage oplosbaarheid in water heeft, in een vaste matrix van een in water oplosbaar polyalkyleenglycol als drager.
ZA87279B (en) * 1986-01-17 1987-09-30 Chugai Pharmaceutical Co Ltd Method for production of stable nicorandil preparation
US4859470A (en) * 1988-06-02 1989-08-22 Alza Corporation Dosage form for delivering diltiazem
HU206824B (en) * 1990-08-24 1993-01-28 Biogal Gyogyszergyar Process for the production of a table crystallizing in the monoclinic system, which contains light-, heat-, and moisture- sensitive active agents
JP2820829B2 (ja) * 1991-03-07 1998-11-05 武田薬品工業株式会社 有核散剤およびその製造方法
JPH04346929A (ja) * 1991-05-22 1992-12-02 Takada Seiyaku Kk 光に安定なメシル酸ブロモクリプチン製剤
ATE214596T1 (de) * 1995-04-14 2002-04-15 Pharma Pass Feste zusammensetzungen mit einem nicht-amorphem wirkstoff und polyäthylenoxyd
RU2092161C1 (ru) * 1995-06-23 1997-10-10 Санкт-Петербургская Государственная Химико-Фармацевтическая Академия Средство с регулируемым высвобождением пентоксифиллина
ATE212550T1 (de) * 1997-08-01 2002-02-15 Elan Corp Plc Tiagabinhaltige arzneizubereitungen mit gesteuerter wirkstoffverabreichung
DE69815003T2 (de) * 1997-09-10 2004-04-01 Takeda Chemical Industries, Ltd. Stabilisierte pharmazeutische Zusammensetzung

Also Published As

Publication number Publication date
WO2001010466A1 (fr) 2001-02-15
EP1205190A1 (en) 2002-05-15
AU6182100A (en) 2001-03-05
HUP0202495A3 (en) 2004-05-28
HU229295B1 (en) 2013-10-28
NO331834B1 (no) 2012-04-16
PL200645B1 (pl) 2009-01-30
ATE324909T1 (de) 2006-06-15
CN1193792C (zh) 2005-03-23
KR100507400B1 (ko) 2005-08-10
AU769807B2 (en) 2004-02-05
NO20020516L (no) 2002-02-01
RU2220715C2 (ru) 2004-01-10
EP1205190A4 (en) 2004-01-21
PT1205190E (pt) 2006-09-29
NO20020516D0 (no) 2002-02-01
CN1373673A (zh) 2002-10-09
JP3462490B2 (ja) 2003-11-05
ES2262528T3 (es) 2006-12-01
HUP0202495A2 (hu) 2002-11-28
DE60027728T2 (de) 2007-04-26
MXPA02001267A (es) 2002-08-12
CA2387705A1 (en) 2001-02-15
CA2387705C (en) 2009-06-30
DE60027728D1 (de) 2006-06-08
DK1205190T3 (da) 2006-08-14
EP1205190B1 (en) 2006-05-03
KR20020046277A (ko) 2002-06-20

Similar Documents

Publication Publication Date Title
EP1205190A4 (en) STABLE MEDICAL COMPOSITIONS FOR ORAL USE
RU2002102701A (ru) Стабильная пероральная образующая гидрогель, фармацевтическая композиция, способ ее получения, способ предотвращения изменений высвобождения лекарственного средства, способ увеличения физической стабильности пероральной композиции
GEP20022851B (en) Flash-Melt Oral Dosage Formulation
IE970588A1 (en) Controlled release pharmaceutical compositions containing tiagabine
DE60036807D1 (de) Verfahren zur herstellung eines pharmazeutischen kaugummis
WO2004108162A3 (en) Controlled release pharmaceutical composition
ATE130758T1 (de) Arzneimittel zur intranasalen verabreichung, die ketorolac r enthalten.
DE69528838T2 (de) Verbesserte,ibuprofen und codein enthaltende,pharmazeutische zusammensetzungen
IL119684A (en) Long lasting release nifedipine preparation in form of press coated tablets
DE69201956D1 (de) Pyrrolidin- und thiazolidinderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
ATE108650T1 (de) Methode und zusammensetzung zur oralen verabreichung von bioaktiven mitteln zur peyer's flecken.
WO2002098345A8 (fr) Utilisation d'un antioxydant pour le traitement et/ou la prevention des affections oculaires de surface
CA2143413A1 (en) Local Drug Delivery Film, for Periodontal Treatment
BG105173A (en) Novel salt form of pantoprazole
McCourt et al. Fluoride release from fluoride-containing liners/bases.
ATE158504T1 (de) Brausemischungen enthaltend ibuprofen und verfahren
NL8600302A (nl) Farmaceutische preparaten met analgetische werkzaamheid, alsmede de bereiding en toepassing ervan.
DE69723024D1 (de) Pharmazeutische Zusammensetzungen mit kontrollierter Freisetzung zur oralen Verabreichung enthaltend Nifedipin als Wirkstoff
ATE367153T1 (de) Multipartikuläre arzneizusammensetzungen mit gesteuerter wirkstoffabgabe enthaltend selektive inhibitoren der serotoninwiederaufnahme
DE69406853D1 (de) Alpha Aminosäurederivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
DE69634080D1 (de) Mittel zur verhinderung der truebung der vorderen linsenkapsel
WO2006053089A3 (en) Methods and formulations for making pharmaceutical compositions containing bupropion
WO1999047172A3 (en) Oral pharmaceutical compositions to be taken without liquids, which contain inclusion complexes
DE69209916D1 (de) Oral anzuwendende Arzneimittel Dapiprazol enthaltend
ATE212550T1 (de) Tiagabinhaltige arzneizubereitungen mit gesteuerter wirkstoffverabreichung